Biofrontera Inc. (NasdaqCM: BFRI)
Health Care · Pharmaceuticals · US
$0.97
-4.43% today · +3.0% 1Y
Biofrontera Inc. (NasdaqCM: BFRI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.41M and employs 89 people.
Over the last twelve months the share price has gained 3.0%, trading between 0.55 and 1.66.
Tweenvest scores Biofrontera Inc. across four factors: quality 53/100, value 67/100, growth 74/100. Its strongest factor is growth.
BFRI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.41M
- Revenue (TTM)
- $46.17M
- P/E
- —
- EPS
- -0.54
- Dividend yield
- —
- Beta (5Y)
- 0.88
- 52-week high
- $1.66
- 52-week low
- $0.55
- Avg volume (3M)
- —
- Shares outstanding
- 14.85M
- Employees
- 89
- Next earnings
- —
About Biofrontera Inc.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
- ISIN
- US09077D2099
- Founded
- 2015
- Listed since
- Oct 29, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vyome Holdings, Inc.NasdaqCM: HIND | $14.67M | $2.09 | +9.42% |
| Ambee Pharmaceuticals PLCDSE: AMBEEPHA | $14.65M | Tk752.00 | +1.43% |
| Godavari Drugs LimitedBSE: 530317 | $14.65M | Rs140.00 | +18.59% |
| Union Korea Pharm Co., Ltd.KOSDAQ: A080720 | $14.59M | ₩— | — |
| Bio Essence CorporationOTCPK: BIOE | $14.37M | $0.27 | — |
| Lobe Sciences Ltd.CNSX: LOBE | $14.28M | CA$0.06 | +9.09% |
| Lipocine Inc.NasdaqCM: LPCN | $14.18M | $1.72 | -16.10% |
| Panchsheel Organics LimitedBSE: 531726 | $14.04M | Rs103.15 | +0.29% |
Figures last refreshed Oct 11, 2026.